3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
27
Gastrointestinal
9
Breast
9
Thoracic
4
Head & Neck
2
Gynecologic
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
7
Neoplasms
3
Multiple Myeloma
3
Leukemia
3
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Sexually Transmitted Diseases
1
Prostatic Neoplasms
1
Osteonecrosis
1
Neoplasms, Plasma Cell
1
Mastocytosis, Systemic
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypertension
1
Hypergammaglobulinemia
1
Hematologic Neoplasms
1
Exanthema
1
Disease
1
Dermatitis, Seborrheic
1
Depression
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Anxiety Disorders
1
Acquired Immunodeficiency Syndrome
1
Interventions
Vorinostat
3
Azacitidine
3
venetoclax
2
trametinib
2
ruxolitinib
2
pertuzumab
2
palbociclib
2
olaparib
2
durvalumab
2
dabrafenib
2
copanlisib
2
aflibercept
2
abiraterone
2
Sunitinib
2
Specimen Handling
2
Sirolimus
2
Nivolumab
2
Immunoglobulin G
2
HhAntag691
2
Doxorubicin
2
Disulfides
2
Dasatinib
2
Cyclophosphamide
2
Biopsy
2
Afatinib
2
Ado-Trastuzumab Emtansine
2
2C4 antibody
2
ulixertinib
1
tremelimumab
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Interviews as Topic
×
Lymphoid
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled